Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > What have we got here?

<< Previous

Bullboard Posts

Next >>

Comment by 13X2413on Jun 20, 2023 12:50pm

140 Views

Post# 35505532

RE:RE:RE:RE:RE:What have we got here?

Noteable.....love all your positivity. The dated info has to stop. We need fresh info. No one cares about old news which has been factored into the current share price.

What scares me is that the big players don't seem impressed about the previous news. If they were as hopeful as you, we wouldn't be floundering at this level.

We need news, not pipe dreams about buyouts!

<< Previous

Bullboard Posts

Next >>

Near-term and long-term outlook for gold